Economic Impact Report. CIRM’s impact on creating jobs, generating income and taxes for California. The total impacts on the California economy are estimated to be:

There is no shortage of myths and misconceptions when it comes to stem cell research and regenerative medicine. Here we address the most common concerns. If you have more questions that aren’t addressed here, please visit our other Stem Cell FAQ pages. Stem cell research, like any field within ...

CIRM-Funded Internship Programs: SPARK, Bridges, COMPASS, & Scholars CIRM’s mission is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world.

Stem cells have the potential to treat a wide range of diseases. Here, discover why these cells are such a powerful tool for treating disease and what hurdles experts face before new therapies reach patients. When most people think about about …

To Submit an Application: Go to the Grants Management Portal (https://grants.cirm.ca.gov) and log in with your existing CIRM Username and Password.If you do not have a Username, Click on the “New User” link and follow the instructions to create a CIRM Username and password. After logging in, click on the Menu tab. Select the tab labeled “Open Programs“.

2024年3月29日 · Advancing Antiviral Research Through Stem Cell Analysis. A $1.5 million award to Michael Wells, PhD, of UCLA, will support research aiming to identify the genetic and molecular risk factors underlying disease-causing viral infections in multiple diverse ancestral populations.

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world-class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world. In support of this mission, CIRM is …

Created by Californians. Curing the World. About CIRM. About Us. Our Mission. Leadership. Our History. Annual Reports

2024年9月26日 · Discovery. The Foundation Awards (DISC0) Request For Application (RFA) is available to access on the Discovery Stage Research Funding Opportunities page.. Application Availability: Applications will be made available in the Grants Management Portal on October 18, 2024. Submission Deadline: The deadline for DISC0 applications is April 10, 2025.

Clinically Compatible hPSC lines for Therapeutic Development and Commercialization. Any applicant who intends to develop an allogeneic human pluripotent stem cell (hPSC)-derived therapeutic with CIRM funding must establish evidence of disease/injury modifying activity using a clinically compatible cell source that can be translated for clinical use.